Rheumatoid arthritis (RA) is treated with medications that slow the disease, reduce inflammation, and prevent joint damage, often combined with exercise and lifestyle changes. The goal of modern treatment is remission, meaning the disease is essentially inactive, and about 25 to 35% of patients achieve that with current therapies. Treatment typically starts within weeks of diagnosis because early, aggressive intervention gives the best long-term outcomes.
The Treat-to-Target Approach
RA treatment follows a strategy called “treat to target.” Your rheumatologist sets a specific goal, usually remission or low disease activity, and adjusts your medications until you reach it. The European Alliance of Associations for Rheumatology (EULAR) recommends seeing at least a 50% improvement in disease activity within 3 months and reaching the treatment target by about 6 months. If you’re not hitting those benchmarks, your doctor will escalate to a stronger medication or add a second one.
“Sustained remission” means maintaining that inactive state for at least 6 months. In practice, remission is defined by having no more than one swollen joint, no more than one tender joint, and normal levels of inflammation in your blood. For people with long-standing RA, low disease activity rather than full remission may be a more realistic target, but the principle is the same: measure, adjust, and don’t settle for uncontrolled symptoms.
First-Line Medication
Methotrexate is the cornerstone of RA treatment and almost always the first medication prescribed. It works by dialing down the overactive immune response that drives joint inflammation and damage. The typical starting dose is once per week (not daily), and your doctor adjusts it based on how well you respond and how you tolerate it. Most people take it as a pill, though an injectable version is available and can cause fewer stomach side effects.
Methotrexate takes time to work. You won’t feel a difference in the first week or two. Most people notice improvement within 6 to 12 weeks, and the full effect can take 3 to 6 months. During that waiting period, your doctor may prescribe a short course of corticosteroids to control inflammation and pain while the methotrexate builds up in your system. This is called “bridging therapy,” and it’s meant to be temporary, not a long-term solution, since corticosteroids carry significant side effects with prolonged use.
Before starting methotrexate, you’ll have blood tests to check your liver function and blood cell counts. Regular blood monitoring continues throughout treatment because the drug can affect your liver and suppress blood cell production. These checks are routine and straightforward, but they’re a non-negotiable part of being on the medication.
Biologic Therapies
If methotrexate alone doesn’t get your disease under control, the next step is usually adding a biologic medication. Biologics are lab-engineered proteins that block specific parts of your immune system. The most commonly used class targets a protein called TNF, which fuels inflammation in RA joints. TNF blockers include etanercept (Enbrel), adalimumab (Humira), infliximab (Remicade), certolizumab pegol (Cimzia), and golimumab (Simponi).
These medications are given by injection or infusion. Some you can inject yourself at home every one to two weeks. Others require an IV infusion at a clinic every several weeks. They’re often used alongside methotrexate because the combination tends to work better than either drug alone.
TNF blockers aren’t the only biologic option. Other biologics work by targeting different immune pathways, blocking certain white blood cells, or interrupting the signaling between immune cells. If one biologic doesn’t work or causes side effects, your rheumatologist can switch to another with a different mechanism. It’s common for people to try more than one before finding the right fit.
Because biologics suppress parts of the immune system, they increase your risk of infections. You’ll be screened for tuberculosis and hepatitis B before starting, and you’ll need to be vigilant about infections while on treatment. Most people manage this without major problems, but it’s something to be aware of.
Oral Targeted Therapies
A newer class of medications called JAK inhibitors offers an alternative to biologics. These are pills taken daily that block specific enzymes inside immune cells, interrupting the inflammatory signals before they start. Three JAK inhibitors are approved for RA: tofacitinib, baricitinib, and upadacitinib. They’re typically prescribed when methotrexate and at least one biologic haven’t worked well enough.
JAK inhibitors can work relatively quickly, with some people noticing improvement within the first few weeks. The convenience of a daily pill rather than injections appeals to many patients. However, these medications carry their own safety considerations, including increased risks of infections, blood clots, and cardiovascular events in certain populations. Your rheumatologist will weigh your personal risk factors when deciding whether a JAK inhibitor is appropriate.
How Realistic Is Remission?
Remission rates vary depending on how strictly you define it. In a large real-world study across the Asia-Pacific region involving over 2,000 patients, about 25% achieved remission by the strictest criteria. A separate study spanning 24 countries in Europe and the Americas found that roughly 14 to 20% of patients reached remission. These numbers might sound modest, but they represent a dramatic improvement over what was possible just a few decades ago, when joint destruction and disability were common outcomes.
Even when full remission isn’t achievable, low disease activity is a meaningful outcome. Many people with well-controlled RA live with minimal pain and little to no joint damage progression. The key is starting treatment early and staying consistent with medication adjustments when the current plan isn’t working well enough.
Exercise and Physical Therapy
Exercise is not optional in RA management. The American College of Rheumatology recommends it for people with RA, and research shows that weight-bearing exercises are beneficial rather than harmful to affected joints. The four main types to incorporate are flexibility exercises (to keep joints mobile), strengthening exercises (to support and protect joints with stronger muscles), aerobic activities like walking, swimming, or cycling (for cardiovascular health and weight control), and mindful movement practices like yoga or tai chi (for balance and posture).
If morning stiffness makes early activity difficult, starting with gentle stretches or range-of-motion exercises can help loosen things up. Many people with RA find that working with a physical therapist initially helps them build confidence and learn which movements are safe during flares versus periods of low disease activity. Over time, regular exercise reduces fatigue, improves mood, and helps maintain the joint function that medications are working to preserve.
Diet and Inflammation
Diet alone won’t replace medication, but emerging evidence suggests it can complement your treatment. The ADIRA trial (Anti-inflammatory Diet in Rheumatoid Arthritis) tested a diet rich in omega-3 fatty acids, dietary fiber, and probiotics in 50 RA patients over 10 weeks and measured its effects on disease activity markers, including C-reactive protein, joint swelling, and joint tenderness. The premise is that certain dietary patterns can nudge inflammation levels down alongside your medications.
In practical terms, this looks a lot like a Mediterranean-style eating pattern: fatty fish, whole grains, fruits, vegetables, nuts, and olive oil, with less red meat, processed food, and saturated fat. You don’t need a rigid protocol. Consistently choosing anti-inflammatory foods over time can support your overall treatment without requiring dramatic dietary changes.
When Surgery Becomes an Option
Surgery is reserved for cases where medications and other treatments haven’t prevented significant joint damage. It’s always an elective decision, made after nonsurgical options have been thoroughly tried. The most common procedures fall into two categories based on how far the disease has progressed.
In earlier stages, when the joint lining (synovium) is inflamed but the joint itself isn’t yet destroyed, a procedure called synovectomy removes the inflamed tissue. This can be done arthroscopically through small incisions and may relieve pain and slow damage in that joint. In more advanced cases, where the joint cartilage and bone are significantly eroded, total joint replacement becomes the primary surgical option. Knees and hips are the most commonly replaced joints in RA, though shoulders, elbows, and smaller joints can also be addressed. Modern joint replacements last 15 to 20 years or more for most people, and the procedure reliably reduces pain and restores function.